SEATTLE--(BUSINESS WIRE)--Blaze Bioscience, the Tumor Paint Company ®, a biotechnology company focused on guided cancer therapy, today announced the publication of a manuscript in Cancer Research ...

SEATTLE--(BUSINESS WIRE)--Blaze Bioscience, Inc., the Tumor Paint Company ®, a biotechnology company dedicated to improving the lives of cancer patients through development and commercialization of ...

Seattle-based Blaze Bioscience has nabbed a $1.5 million Small Business Innovation Research (SBIR) Phase II award from the National Cancer Institute (NCI) to continue researching its product, called ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by John Cook on Dec 3, 2013 at 7:21 am ...

SEATTLE--(BUSINESS WIRE)-- Blaze Bioscience, Inc., a biotechnology company dedicated to developing products that assist surgeons in their quest to improve the lives of cancer patients, announced today ...

Blaze Bioscience, a company working on a fluorescent molecule to help surgeons better remove tumors, reported data from a phase 1 trial testing its “tumor paint” in adults with gliomas, a type of ...

Less than two years after its founding and 10 months after licensing its technology from Seattle's Fred Hutchinson Cancer Research Center, privately held Blaze Bioscience Inc. raised $5 million in a ...